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Background. Tuberculosis (TB) is a leading cause of morbidity and mortality worldwide. In Armenia, case reports of active TB
increased from 590 to 1538 between 1990 and 2003. However, the TB case detection rate in Armenia in 2007 was only 51%,
indicating that many cases go undetected or that suspected cases are not referred for conﬁrmatory diagnosis. Understanding
why Armenians do not seek or delay TB medical care is important to increase detection rates, improve treatment outcomes, and
reduce ongoing transmission. Methods. Two hundred-forty patients hospitalized between August 2006 and September 2007 at two
Armenian TB reference hospitals were interviewed about symptoms, when they sought medical attention after symptom onset,
outcomes of their ﬁrst medical visit, and when they began treatment after diagnosis. We used logistic regression modeling to
identify reasons for delay in diagnosis. Results. Fatigue and weight loss were signiﬁcantly associated with delay in seeking medical
attention[aOR = 2.47(95%CI = 1.15,5.29);aOR = 2.99(95%CI = 1.46,6.14),resp.],whilehavingnightsweatsprotectedagainst
delay [aOR = 0.48 (95%CI = 0.24, 0.96)]. Believing the illness to be something other than TB was also signiﬁcantly associated
with delay [aOR = 2.63 (95%CI = 1.13, 6.12)]. Almost 20% of the 240TB patients were neither diagnosed at their ﬁrst medical
visit nor referred for further evaluation. Conclusions. This study showed that raising awareness of the signs and symptoms of TB
among both the public and clinical communities is urgently needed.
1.Introduction
Although tuberculosis (TB) is both preventable and curable,
it remains a leading infectious cause of morbidity and mor-
tality worldwide. In 2007, the World Health Organization
(WHO) estimated 9.27 million new cases of TB, with 1.3
million deaths [1]. To decrease the impact of TB, the United
Nations included TB prevention and control among its
eight Millennium Development Goals, with a proposal to
reduce TB incidence to half the 1990’ level by 2015 [2].
To measure and achieve this, the World Health Assembly
(WHA) highlighted two indicators: 70% global and in-
country case detection rates and successful treatment of 85%
of cases [1].
Many countries, including the majority of those belong-
ing to the former Soviet Union (FSU), have been unable
to meet these targets [3]. The breakup of the Soviet Union
had devastating eﬀects on public health infrastructure and
the ability to deliver care. Severe economic and political
turmoilmadehealthsystemreconstructiondiﬃcult,creating
favorable conditions for the rise of infectious diseases such as
TB.2 Interdisciplinary Perspectives on Infectious Diseases
In the Republic of Armenia—a landlocked country in
the southern Caucasus with a population of approximately
3 millions—case reports of active TB increased almost three
fold between 1990 and 2003, from 590 to 1538 cases [4].
Although epidemiologic data are at times discrepant, in-
country experts recognized that these data likely underesti-
matedtrueTBmorbidity[4].Armenia,alongwithmostFSU
countries, is one of the WHO European Region’s 18 High
Priority Countries for TB control [3].
In addition to high levels of TB in many countries,
the WHO European Region has the highest levels of drug-
resistantformsofTBintheworld[3].In2007inArmenia,an
estimated9.4%ofnewsputum-smearpositivecasesand43%
of previously-treated cases had multidrug resistant forms of
TB [5]. In-country experts attribute such high levels of drug
resistance to treatment default and failure.
Over the past decade, Armenia has made considerable
progress in rebuilding its TB control program; however, it
has been a slow process, made diﬃcult by a lack of precedent
(no national TB program existed in the country prior to
independence), a lack of public health infrastructure, and
unreliable communication systems [6].
Therefore, it is not surprising that, as of 2007, Armenia
had been unable to meet the WHA TB targets. A case
detection rate of 51% for new sputum-smear positive cases
for that year shows that a substantial proportion of TB cases
were either not detected or not referred for conﬁrmation
[5].
Many factors likely contribute to the low TB case detec-
tion rate in Armenia. Numerous countries have conducted
studies [7–13] to identify factors related to diagnostic delays
of TB and, in a systematic review by Storla, Yimer and Bjune
of 58 such studies, the authors identiﬁed sociodemographic
and economic factors as well as the amount of time it took to
reacha healthfacility, andthe type and numberof healthcare
providers visited as the most common determinants of delay
worldwide [14].
However, studies to identify speciﬁc risk factors for the
Armenian population have never been conducted. Under-
standing why citizens do not seek medical attention, do not
pursue specialized attention following referral, or do not
receive a referral for additional diagnostic services is impor-
tant. Delayed diagnosis or delayed initiation of treatment
increases the risk of more severe and harder-to-treat forms
of TB, and also increases the risk of ongoing transmission.
Therefore, we conducted this study to understand and
assess the barriers to proper and timely TB diagnosis and
treatment.
2. Methods
We conducted a systematic study of patients hospitalized
from August 2006 until September 2007 at the Yerevan
City and the Republican Dispensaries, the two reference
TB hospitals in Armenia. Following focus group discussions
and pilot testing to reﬁne the survey instrument, patient
interviews began in the fall of 2006 and were conducted
by trained students in the public health program of the
American University of Armenia. Students received training
by the study designer (SO) on principles of interview ethics
and interviewing processes.
Most patient interviews were conducted at the Republi-
can Dispensary in Abovian Marz, the national TB diagnostic
and treatment facility to which all suspected cases through-
out the country are referred for diagnostic conﬁrmation.
In the past several years, strong ﬁnancial support has been
provided to Armenia by a number of international orga-
nizations, such as the German Gesellschaft f¨ ur Technische
Zusammenarbeit (GTZ), the Global Fund to Fight AIDS,
Tuberculosis and Malaria, and the Red Cross, which has
enabled both microscopic and culture examinations for
each TB case to be performed at the National Reference
Laboratory located at the Republican TB Dispensary. All
culture-conﬁrmed TB cases are admitted as in-patients
while undergoing the initial phase of therapy. Because all
conﬁrmed TB patients in Armenia are referred to one of
these dispensaries for treatment, this population represents
all known TB cases in the country. Therefore, all culture-
conﬁrmed TB in-patients present at the time of the inter-
viewer visits were eligible for inclusion in the study (the
study group included both new and relapsed patients).
Our systematic sample of the inpatient TB population—in
which interviewers visited every hospital room to identify
patients willing to participate—yielded a participation rate
of approximately 80% (a total of 240 patients).
Interviewers collected demographic information and
asked each patient to recall when they ﬁrst began to feel ill,
what symptoms they experienced, how long after symptom
onset they waited to see a doctor, their reasons for delaying
medical evaluation, the type of facility at which they ﬁrst
sought care, the initial diagnosis, if they had been referred
forfurtherevaluation,andtheiradherencetotreatmentonce
diagnosed with TB. In 2006, 129 of the planned 250 surveys
were completed. Data collection resumed in the fall of 2007
a n dat o t a lo f2 4 0i n t e r v i e w sw e r ec o n d u c t e d .
2.1. Statistical Analysis. Descriptive statistics were calcu-
lated to assess participant socio-demographic characteris-
tics which were then compared to the sociodemographic
characteristics of the Armenian population. Frequency of
symptoms that were experienced by participants prior to
seeking medical care as well as reasons for delay in seeking
medical care were also calculated.
Logistic regression models were used to determine which
factors were most associated with a delay in seeking medical
attention after symptom onset. A review of the relevant
literature failed to identify a standard deﬁnition for patient
delay among persons eventually diagnosed with TB. After
consultations with physicians and others knowledgeable in
the ﬁeld of TB, we determined that for the purposes of
our study, a person was classiﬁed as a “delay” if he or she
experienced hemoptysis or fever for more than three weeks,
or if he or she experienced cough, fatigue, night sweats, or
weight loss for more than six weeks before seeking medical
attention.
Crude odds ratios were calculated for the delay vari-
able against all other variables of interest. Adjusted odds
ratios were obtained using multivariate logistic regressionInterdisciplinary Perspectives on Infectious Diseases 3
modeling techniques. Since we wished to select only those
variables that might be important predictors of delay for
inclusion in the model, a backwards elimination strategy was
employed. Because the number of participants was small
relative to the number of variables we wished to assess,
we divided up the variables and performed two separate
backwards elimination tests. The ﬁrst backwards elimination
modelcontainedonlysociodemographiccharacteristicssuch
as gender, age, marz (region), education level, marital status,
and employment status. The second model included char-
acteristics such as the type of facility at which participants
ﬁrst sought care, their symptoms, if they had knowledge of
prior contact with a TB patient, the year the interview was
conducted, and reasons for delay.
Variables shown to be signiﬁcant in the crude analysis
along with variables selected using the backward elimination
procedures were included in the ﬁnal model and adjusted
odds ratios were calculated. The ﬁnal model included
the following variables: fatigue, night sweats, weight loss,
thinking one had something other than TB, and thinking
that the cost of seeking a medical evaluation would be too
expensive.
Similar techniques were used to identify risk factors for
failure to receive a referral for further evaluation if the
participant was not diagnosed with TB at the ﬁrst medical
visit. Crude odds ratios were calculated for all variables and
then backward elimination analyses were conducted.
AllanalyseswereconductedusingSASstatisticalsoftware
version 9.1 (SAS Institute Inc., Cary, NC, USA).
2.2. Ethics and Data Conﬁdentiality. Ethical approval for
this study was obtained from the American University of
Armenia’s Institutional Review Board and was carried out in
accordance with Armenian data collection and conﬁdential-
ity regulations. Written informed consent was obtained from
all participants prior to study enrollment.
3. Results
3.1. Sociodemographic Characteristics. There were a total of
887 cases notiﬁed to the Republican Dispensary during our
study period, August 2006–September 2007. Cumulatively,
our study took place over approximately four months during
this 14-month period, and our 240 participants represent
27.1% of these cases.
Of those who were enrolled, 80% were male, 54% were
married, 82% were unemployed, 10% had less than a junior-
high education, and 30% were from Yerevan (Table 1).
Ages of participants ranged from 8–77 (mean: 38.1; median:
3 8 ) .W h e nw ec o m p a r e dan u m b e ro fs o c i o d e m o g r a p h i c
characteristics of the participants to those of the popula-
tion of Armenia to assess how representative TB patients
may be of the general population, we found that the
regional distribution of participants, overall, was similar to
the regional composition of Armenia; the distributions of
other sociodemographic variables such as gender, marital
and employment status, age, and education level showed
a number of signiﬁcant diﬀerences between our population
of TB patients and the Armenian population.
3.2. Health-Seeking Patterns. Of the 209 participants for
which health-care seeking information was available, 179
(86%) ﬁrst sought medical care in the public sector.
This included polyclinics, TB cabinets (outpatient clinics
located at the sub-marz level that serve primarily to detect
suspected TB cases), TB dispensaries (hospitals that serve
to diagnose, conﬁrm, and treat TB patients), as well as
regional,armyandprisonhospitals.Theremaining30(14%)
participants ﬁrst sought care from the private sector, either
at private, professional clinics or from “informal” clinics or
neighbors.
Ninety-ﬁve (40%) participants were diagnosed with TB
at their initial visit. Of those, 83 (87%) received a referral
for further evaluation, and 73 (77%) of those reported
that they sought the referral as instructed. Of the 139
(59%) participants who were not diagnosed at their ﬁrst
visit, 113 (81%) received a referral for further evaluation.
Ninety (80%) reported seeking the referral when told to. We
detected no signiﬁcant diﬀerences between participants who
reported referral compliance and participants who did not.
3.3. Symptom Characteristics. The symptoms most fre-
quently reported by participants were fatigue (71%), cough
(70%), fever (68%), night sweats (66%), and weight loss
(64%). When asked why they did not visit their healthcare
provider closer to the onset of symptoms, most (58%)
reportedtheythoughttheirillnesswasnotseriousandwould
goawayonitsown(Table2).Thirty-four(18%)thoughtthey
had something other than TB. Of these, 10 (30%) thought
they had the ﬂu, 6 (18%) thought they had pneumonia, and
8 (24%) took antibiotics such as gentamicin, penicillin, or
ceftrioxone.
3.4. Delay. Of the 240 participants, information about time
from onset of symptoms to the ﬁrst medical visit was
available for 218 (91%) participants. Of these, 89 (41%) met
the criteria for being a “delay” patient.
3.5. Factors Associated with Delay. Results of the crude and
logistic regression analyses revealed no signiﬁcant associa-
tions between delay and sociodemographic factors (Table 3).
Symptoms signiﬁcantly associated with delay were fatigue
and weight loss [aOR = 2.47 (95%CI = 1.15,5.29); aOR =
2.99 (95%CI = 1.46,6.14)] (Table 3). Patients with night
sweats were less likely to delay [aOR = 0.48 (95%CI =
0.24,0.96)]. Patients who thought they had something other
than TB were also signiﬁcantly more likely to delay a visit to
their physician [aOR = 2.63 (95%CI = 1.13,6.12)].
Beginning January 1, 2007, new national TB payment
policies were implemented whereby all TB diagnostic and
treatment services became free to the patient, regardless
of ability to pay. One hundred twenty-nine (54%) surveys
were conducted prior to the policy change, while 111 were
conducted after. Because we had asked questions regarding
cost as a potential barrier, we included a “prepolicy change”
and a “postpolicy change” factor in the analysis. However,
havingbeenenrolledintothestudypriortothepolicychange
was not statistically associated with being a delay case.4 Interdisciplinary Perspectives on Infectious Diseases
Table 1: Sociodemographic characteristics of tuberculosis patients, Republic of Armenia, September 2006–August 2007.
Characteristic Armenia N∗ % Participants N % P-value
Gender
Male 1,407,220 47 192 80 <. 0001
Female 1,595,374 53 48 20
Total 3,002,594 240
Age (years)
0–14 744,191 25 2 0.8 <. 0001
15–24 547,700 18 50 20.8 .321
25–34 382,783 13 57 24.2 <. 0001
35–44 470,124 16 52 22 .0185
45–54 335,168 11 49 20.8 .0002
55–64 216,937 7.2 14 5.9 .3927
≥65 305,691 10 16 6.8 .0364
Marz
Aragatsotn 126,278 4.2 13 5.4 .4108
Ararat 252,665 8.4 30 12.5 .0548
Armavir 255,861 8.5 30 12.5 .061
Gegarkunik 215,371 7.2 13 5.4 .2173
Kotayk 241,337 8 35 14.6 .0038
Lori 253,351 8.4 15 6.3 .1806
Shirak 140,318 4.7 6 2.5 .029
Syuniq 134,061 4.5 4 1.7 .0008
Tavush 121,963 4.1 16 6.8 .0966
Vayots Dzor 53,230 1.8 3 1.3 .4941
Yerevan 1,091,235 37 73 30.4 .0368
Republic of Georgia 2 0.8
Education N = 2,922,464
†
None 16,203 1 1 0.4 .1409
Elementary school 226,453 13 22 9.2 .0244
Middle school 428,367 25 109 45.5 <. 0001
High school 928,704 55 84 35 <. 0001
University 92,712 5.5 24 10 .0201
Marital Status N = 2,432,968
Not married 643,025 26 86 35.8 .0024
Married 1,511,305 62 130 54.2 .014
Divorced, Live Separately, Widow 278,638 12 24 10 .4386
Employment Status N = 2,432,968
‡
Employed 1,020,809 42 43 17.9 <. 0001
Unemployed 1,412,159 58 197 82.1
∗National Statistical Service of the Republic of Armenia. National Census 2001, Republic of Armenia. Yerevan 2003 [15].
Signiﬁcantly diﬀerent at α = 0.05.
†Data collected for Armenian population aged 7 years and older.
‡Data collected for Armenian population aged 15 years and older.
3.6. Failure to Be Referred. Twenty-six participants, repre-
senting 19% of the participant population not diagnosed
on the ﬁrst visit to a healthcare facility, were not referred
by their physician for further evaluation. We attempted to
identify risk factors associated with this failure using the
samemethodsthatwereusedtoidentifyriskfactorsfordelay.
Variables considered were participants’ sociodemographic
characteristics (gender, age, marz, educational level, marital
and employment status), the type of facility at which they
ﬁrst sought care, the type of symptoms they reported, and
prior contact with a TB case. However, due to small cell
counts for many of these variables, we did not have suﬃcient
power to do these analyses.
3.7. Treatment Delay. Once diagnosed, 230 (96%) partici-
pants were instructed to start medication. Of those, 226Interdisciplinary Perspectives on Infectious Diseases 5
Table 2: Reasons tuberculosis patients postponed seeking initial medical care after onset of symptoms, Republic of Armenia, September
2006–August 2007.
Reason∗ N %
Thought not serious, would pass on own 107 57.8%
Thought something else; used other meds to treat 34 18.4%
Could not aﬀo r dt og ot oh e a l t hf a c i l i t y 1 6 8 . 6 %
Did not have time to go to health facility 12 6.5%
D i dn o tk n o ww h e r et og of o rt r e a t m e n t 5 2 . 7 %
Did not want to go to health facility 5 2.7%
Did not want others to know had TB 4 2.2%
Did not live near health facility 1 0.5%
Don’t Know 1 0.5%
Total 185 100.00%
∗Patients could list more than one reason.
(98%) said they initiated therapy when told to. Lack of
knowledge as to where to get treatment was given as a reason
for delay by two participants, including a man who waited
one month to initiate therapy.
4. Discussion
This study indicates several risk factors for delayed action in
the diagnosis of TB and also reveals some areas for further
investigation.
Fatigue and weight loss were signiﬁcantly associated
with patient delay, indicating that they arouse a low level
of concern among patients. Because unexplained weight
loss, as well as chronic fatigue, can be markers for a
number of potentially severe illnesses, Armenians should be
encouragedtoseekmedicalattentionassoonaspossibleafter
recognition of these symptoms. The possibility that some
of the participants who experienced these symptoms may
have already had other conditions to which they may have
attributedtheirweightlossand/orfatiguewasnotspeciﬁcally
addressed in this study, but should be considered if future
studies of this kind are conducted in this population.
As noted by Storla, Yimer, and Bjune, deﬁnitions of
delay are heterogeneous, as are the risk factors identiﬁed
in studies of this type done elsewhere. Given the lack of a
standard deﬁnition for delay, our cutoﬀ of three weeks was
determined somewhat arbitrarily following consultations
with TB experts; it is slightly shorter than many others
have used in the past [14]. Diﬀerences in our deﬁnition of
delay, along with possible variations in the deﬁnitions of
other variables (i.e., onset of symptoms, ﬁrst contact with
health services, etc.) or in the methods used, may account
for some of the ﬁndings that are inconsistent with many of
the studies done in other parts of the world, which identiﬁed
sociodemographic and economic factors as being associated
with delay. Of course, there are important cultural, social,
and health-care related diﬀerences between Armenia and
many of the other countries we identiﬁed, only one of which,
Estonia, was part of the former Soviet Union, that may be
behind these diﬀerences as well.
Over one-half (59%) of the participants were not
diagnosed on their ﬁrst visit to a healthcare provider,
although the majority (81%) did receive a referral for
further evaluation. However, the reasons why almost 20%
of participants did not receive a referral remain unclear.
Further study is needed in order to clarify and improve this
problem.Itwouldalsobeusefultoknowwhatfactorspushed
patients who did not receive a referral to pursue further
medical evaluation. Although many of them likely did so
because their symptoms did not improve or worsened, it is
possible that their perseverance might be attributed to some
protective factor against delay in seeking medical care. If so,
the identiﬁcation of this factor would be important to TB
control eﬀorts.
Additional information such as the average number of
patient visits to a health center before a correct diagnosis is
made and the level of knowledge about TB among medical
staﬀ is important to know. In the past few years, as part of
an overall plan to decentralize health services and strengthen
local primary care services, the Ministry of Health closed all
marz- and district-level TB cabinets [16]. Local primary care
physicians and laboratories became responsible for ensuring
proper diagnosis of TB cases, although conﬁrmation is still
done at the national level. This presents new challenges for
local physicians, who may not have much experience with
TB, as well as challenges to existing primary healthcare facil-
ities, which may not have adequate diagnostic capabilities.
Gender was not shown to be a risk factor for delay,
but the male-female ratio in this study is striking. This,
however, does correspond to the average male-female ratio
of patients seen at the Republican Dispensary in 2007, and
WHO TB case notiﬁcation reports show that substantially
more men are detected in Armenia [5]. Men may more
often be subject to situations that place them at higher
risk of TB exposure than women, such as congregate living
conditions due to incarcerations or compulsory military
service, and many men go to Russia—which has a very
high TB burden—to ﬁnd work. However, the possibility that
women may systematically go undetected by TB surveillance
systems should be investigated.6 Interdisciplinary Perspectives on Infectious Diseases
Table 3: Relationship between tuberculosis patient characteristics and delay in seeking health care, Republic of Armenia, September 2006–
August 2007.
Characteristic N = 218 Delayed (%) cOR
a 95%CI
a aOR
ab 95% CI Model
c
Gender 1
Male 192 73 (38) 1.27 (0.64, 2.51)
Female 48 16 (33.3) 1
Age 1
0–24 44 17 (38.6) 1
25–34 50 16 (32) 0.75 (0.32, 1.75)
35–44 49 21 (42.9) 1.19 (0.52, 2.73)
45–54 46 22 (47.8) 1.46 (0.63, 3.37)
≥55 29 13 (44.8) 1.29 (0.5, 3.34)
Marz 1
Aragatsotn 13 5 (2.3) 0.84 (0.25, 2.87)
Ararat 28 12 (5.5) 1.01 (0.41, 2.49)
Armavir 27 13 (6) 1.25 (0.5, 3.1)
Gegarkunik, Syuniq, &
Vayots Dzor∗ 18 7 (3.2) 0.86 (0.29, 2.51)
Lori & Shirak∗ 20 5 (2.3) 0.45 (0.16, 1.29)
Kotayk 34 15 (6.9) 1.06 (0.46, 2.48)
Tavush 16 6 (2.8) 0.81 (0.26, 2.51)
Yerevan 61 26 (11.9) 1
Education 1
None/Elementary school 19 9 (4.1) 0.98 (0.29, 3.31)
Middle school 99 35 (16.1) 0.6 (0.24, 1.49)
High school 77 34 (15.6) 0.86 (0.34, 2.19)
University 23 11 (5) 1
Marital status 1
Not married 72 28 (12.8) 0.85 (0.47, 1.53)
Married 126 54 (24.8) 1
Divorced 14 5 (2.2) 0.74 (0.23, 2.34)
Live separately 00 0 0
Widow 6 2 (1) 0.67 (0.12, 3.77)
Employment status 1
Unemployed 179 74 (33.9) 1.15 (0.56, 2.33)
Employed 39 15 (6.9) 1
Payment policy change∗∗ 1
Before 113 46 (40.7) 0.99 (0.58, 1.7)
After 105 43 (41) 1
Type of facility where ﬁrst
sought care
2
Public 166 68 (41) 0.86 (0.38, 1.97)
Private 27 12 (44.4) 1
Symptoms 2
Cough 164 71 (43.3) 1.53 (0.80, 2.91)
Fever 153 66 (43.1) 1.39 (0.76, 2.52)
Hemoptysis 41 15 (36.6) 0.8 (0.4, 1.62)
Fatigue 160 75 (46.9) 2.77† (1.41, 5.46) 2.47† (1.15, 5.29)
Night sweats 151 61 (40.4) 0.94 (0.53, 1.69) 0.48† (0.24, 0.96)Interdisciplinary Perspectives on Infectious Diseases 7
Table 3: Continued.
Characteristic N = 218 Delayed (%) cOR
a 95%CI
a aOR
ab 95% CI Model
c
Weight loss 150 73 (48.7) 3.08† (1.62, 5.88) 2.99† (1.46, 6.14)
Headaches/Dizziness 7 2 (28.6) 0.57 (0.05, 3.59)
Abdominal discomfort 14 9 (64.3) 2.79 (0.90, 8.63)
Insomnia 5 3 (60) 2.22 (0.25, 26.94)
Chest pain 12 5 (41.7) 1.04 (0.25, 3.94)
Back pain 12 6 (50) 1.48 (0.38, 5.74)
Leg Pain 2 1 (50) 1.46 (0.09, 23.56)
Other symptoms 17 8 (47.1) 1.32 (0.49, 3.56)
Known contact with a TB case 2
Yes 47 24 (51.1) 1.7 (0.89, 3.26)
No 171 65 (38) 1
Reasons for delayed medical
evaluation
2
Thought not serious 102 41 (40.2) 0.95 (0.55, 1.64)
Thought something else 30 17 (56.7) 2.11 (0.97, 4.59) 2.63
† (1.13, 6.12)
Did not know where to go 4 3 (75) 6.02 (0.58, 298.9)
Did not have time 10 4 (40) 0.96 (0.19, 4.21)
Could not aﬀord 14 10 (71.4) 3.96† (1.2, 13.04) 3.13 (0.93, 10.58)
Did not want to go 5 4 (80) 6.02 (0.58, 298.9)
Fear of stigma 3 1 (33) 0.72 (0.01, 14.08)
a Crude Odds Ratio, 95% Conﬁdence Interval, and Adjusted Odds Ratios.
bAdjusted for the other variables in the logistic regression model.
cBackwards elimination model in which the variable was included.
∗Stratiﬁcation by marz produced < 5 cell counts in some cases. Where this occurred, marzes were combined with the nearest neighboring marz.
∗∗ As of January 1, 2007, all TB diagnostic and treatment services are free to the patient.
†Signiﬁcant at α = .05.
Similarly, although concern about the cost of medical
service was not shown to be a signiﬁcant predictor of delay
in our analysis, the high level of unemployment among
patientsrelativetotheArmenianpopulationshouldbenoted
(Table 1). Although it is unknown if the unemployment
preceded, or was the result of, the diagnosis of TB, it
is recognized as a disease of poverty, which is why the
government’s willingness to cover TB-related services is
important. It would be worthwhile to monitor the policy’s
eﬀectiveness over the longer-term to see if it has any impact
on case detection rates.
There were several limitations to the study. Problems
with recall are a likely source of bias. Although patients
were newly admitted to the Republican Dispensary, they
included both acute and chronic patients. Chronic patients
were deﬁned as those who had either relapsed or failed
treatment. In general, the initial diagnosis of TB for chronic
participants was more likely made further in the past than
for acute patients. Therefore, their ability to recall onset of
symptoms, who they went to see ﬁrst, and how long they
w a i t e dm i g h tb el e s sa c c u r a t e .N oi n f o r m a t i o nw a sc o l l e c t e d
to determine the length of time from the participants’ ﬁrst
presentation of symptoms to the time of the interview.
This study did not collect any information on partic-
ipants’ HIV status or other relevant comorbidities. HIV
or other immune-suppressing conditions often produce
an atypical TB presentation that can impair a patient’s,
or their clinician’s, ability to detect TB, thus resulting in
a diagnostic delay. The impact on our study, however,
is believed to be negligible, as the estimated HIV/AIDS
prevalence in TB patients in Armenia as of 2002 was 0.2%
[17].
Lastly, as TB hospital in-patients, the participants had
been detected—whether early or late—by the healthcare
system. TB cases who, for whatever reason, had not yet
been detected by existing surveillance methods were not
represented in this study and the reasons for their lack of
detection could not be assessed.
5. Recommendations
Outreach eﬀorts to raise awareness of TB as a public
health concern in Armenia and increase knowledge of its
signs and symptoms are needed. Given a general lack of
recognition about signs and symptoms of TB, and the fact
that some patients self-treat or are prescribed with inap-
propriate antibiotics, information about the consequences of
misusing antibiotics (i.e., drug resistance) should be widely
disseminated, not only to the Armenian public, but to the
medical community as well. Physicians should be aware of
the importance of performing appropriate diagnostic tests
prior to administering therapy.8 Interdisciplinary Perspectives on Infectious Diseases
Better local access to TB services may help to reduce
patient delay due to distance factors and increase referral
compliance, but continuing education of physicians at the
local level such that they will be better equipped to recognize
TB is also important, as many local physicians are general
practitioners, not TB specialists. Physicians should have a
higherindexofsuspicionforTBandreferpatientsforfurther
evaluation more often. Ideally, improving local laboratory
infrastructureandincreasingtheabilitytodiagnoselocally—
including allocation of liquid or solid media to do culture
conﬁrmations and resistance testing (currently done only at
the National Reference Laboratory)—would make follow-up
services easier to deliver and decrease diagnostic turn around
time.Theseinturnwoulddecreasetheamountofcontinuing
transmission in the community and lead to better patient
outcomes.
The case detection rate of 51% is an estimate obtained
using a WHO algorithm [1]. However, reliable estimates of
the TB prevalence in Armenia are lacking. It is therefore hard
to assess the true case detection rate. A population-based
study to determine the prevalence of TB in Armenia should
be done in order to obtain a more accurate picture of the TB
problem as well as the proportion of active TB cases that are
diﬃcult to detect with current surveillance methods.
6. Conclusions
This study showed that patient and provider factors resulted
in diagnostic delays of TB. Identiﬁcation of where these
delays occurred and why will help decision makers target
interventions more eﬀectively. We strongly encourage deci-
sion makers in Armenia to thoroughly investigate all poten-
tial causes of delay—patient, provider, and laboratory—
and improve TB surveillance systems accordingly. Better
surveillance data will give a more reliable picture of the
burden of TB in Armenia and can be used to assess how
well current diagnostic, treatment, and control activities are
working as well as identify ways in which they may be
improved.
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